Researchers found that stereotactic body radiotherapy (SBRT), a form of high-dose radiation delivered in just five sessions, is as safe as conventional treatment, with similar side effects and a ...

The FDA has approved the Lumipulse Plasma Ratio test, a groundbreaking blood test for early dementia detection. This less ...

The United States on Friday approved the first blood test for Alzheimer's, a move that could help patients begin treatment ...

Paul B. Renz, DO, discussed the ideal uses of MR-LINAC in pancreatic, prostate, liver, head and neck, and rectal cancers.

The FDA has cleared the first-ever blood test for early Alzheimer's detection, which the agency says reduces the need for ...

According to the 2022 Global Cancer Observatory (GLOBOCAN) report, Nigeria faces significant cancer challenges, with 127,763 ...

The US Food and Drug Administration has given marketing clearance to a blood test to help diagnose Alzheimer’s disease, ...

The FDA has cleared the Lumipulse G pTau217/β-Amyloid 1-42 Plasma Ratio test, the first blood test for early Alzheimer's ...

One possible explanation for the gap is the availability of highly efficacious CAR-T therapies in the U.S. and Europe serving as later-line therapies to improve survival outcomes. The FDA has also ...

Prostate cancer is one of the most common cancers among men, and researchers are always searching for better ways to treat it. Now, a team of scientists from Columbia University has discovered that a ...

Pancreatic ductal adenocarcinoma, the most common form of pancreatic cancer and the fourth leading cause of cancer-related death, has a 5-year survival rate of less than 10%.1 The impact of pancreatic ...

The United States yesterday approved the first blood test for Alzheimer’s, a move that could help patients begin treatment ...